companydata.dkcompanydata.dk

VITREX MEDICAL A/S: Financial statements 2023

CVR: 14728732

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 28,138,595 and a net result of DKK 1,214,691 compared with DKK 4,052,982 the year before. That is an increase of 5.9% compared with the year before. Equity in the 2023 report amounted to DKK 34,248,035. The solvency ratio was 57%. The company had 68 employees in the financial year.

Gross Profit
DKK 28,138,595
Profit/Loss
DKK 1,214,691
Equity
DKK 34,248,035
Total Assets
DKK 60,113,581
Employees
68

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-28.1M1.2M34.2M68
2022-26.6M4.1M33M73
2021-28.6M5.5M32M68
2020-25.9M7.6M31.5M64
2019-21.6M4.1M24.9M60

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Marcin Sieczek joins the board of VITREX MEDICAL A/SDec 1, 2023

As of December 1, 2023, Marcin Sieczek has joined the board of directors of VITREX MEDICAL A/S.

Teodor Lysák leaves the board of VITREX MEDICAL A/SDec 1, 2023

As of December 1, 2023, Teodor Lysák has left the board of directors of VITREX MEDICAL A/S.

VITREX MEDICAL A/S: The 2022 annual report is outJun 1, 2023

VITREX MEDICAL A/S has published its annual report for 2022. Gross profit came to DKK 26,582,922, and the net result was DKK 4,052,982.

About VITREX MEDICAL A/S

VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.

Source: annual report 2025, Danish Business Authority